Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 20;14(3):96042.
doi: 10.5493/wjem.v14.i3.96042.

Artificial intelligence as a tool in drug discovery and development

Affiliations
Review

Artificial intelligence as a tool in drug discovery and development

Maria Kokudeva et al. World J Exp Med. .

Abstract

The rapidly advancing field of artificial intelligence (AI) has garnered substantial attention for its potential application in drug discovery and development. This opinion review critically examined the feasibility and prospects of integrating AI as a transformative tool in the pharmaceutical industry. AI, encompassing machine learning algorithms, deep learning, and data analytics, offers unprecedented opportunities to streamline and enhance various stages of drug development. This opinion review delved into the current landscape of AI-driven approaches, discussing their utilization in target identification, lead optimization, and predictive modeling of pharmacokinetics and toxicity. We aimed to scrutinize the integration of large-scale omics data, electronic health records, and chemical informatics, highlighting the power of AI in uncovering novel therapeutic targets and accelerating drug repurposing strategies. Despite the considerable potential of AI, the review also addressed inherent challenges, including data privacy concerns, interpretability of AI models, and the need for robust validation in real-world clinical settings. Additionally, we explored ethical considerations surrounding AI-driven decision-making in drug development. This opinion review provided a nuanced perspective on the transformative role of AI in drug discovery by discussing the existing literature and emerging trends, presenting critical insights and addressing potential hurdles. In conclusion, this study aimed to stimulate discourse within the scientific community and guide future endeavors to harness the full potential of AI in drug development.

Keywords: AI-driven medicine; Artificial intelligence; Decision-making; Drug development; Drug discovery; Healthcare; Public health.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All authors declare they have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Identification, screening, and selection of papers to include.
Figure 2
Figure 2
An entire workflow of artificial intelligence applications in drug discovery and development, highlighting the different stages and the corresponding artificial intelligence techniques used. AI: Artificial intelligence; QSAR: Quantitative structure-activity relationship. The figure was generated using brainstorming from OpenAI. (2024). ChatGPT [Large language model]. https://chatgpt.com/c/d95bc2d2-a53a-492d-a78d-6946bc43cef2.

References

    1. Hughes JP, Rees S, Kalindjian SB, Philpott KL. Principles of early drug discovery. Br J Pharmacol. 2011;162:1239–1249. - PMC - PubMed
    1. Bohr H. Chapter 3 - Drug discovery and molecular modeling using artificial intelligence. AI Health. 2020:61–83.
    1. Ekins S, Puhl AC, Zorn KM, Lane TR, Russo DP, Klein JJ, Hickey AJ, Clark AM. Exploiting machine learning for end-to-end drug discovery and development. Nat Mater. 2019;18:435–441. - PMC - PubMed
    1. Zhang L, Tan J, Han D, Zhu H. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug Discov Today. 2017;22:1680–1685. - PubMed
    1. Lavecchia A. Deep learning in drug discovery: opportunities, challenges and future prospects. Drug Discov Today. 2019;24:2017–2032. - PubMed

LinkOut - more resources